Human Nectin-4 Protein, His Tag (MALS verified)
分子別名(Synonym)
NECTIN4,LNIR, PRR4, PVRL4
表達(dá)區(qū)間及表達(dá)系統(tǒng)(Source)
Human Nectin-4, His Tag (NE4-H52H3) is expressed from human 293 cells (HEK293). It contains AA Gly 32 - Ser 349 (Accession # Q96NY8-1).
Predicted N-terminus: Gly 32
蛋白結(jié)構(gòu)(Molecular Characterization)

This protein carries a polyhistidine tag at the C-terminus.
The protein has a calculated MW of 36.0 kDa. The protein migrates as 40 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.
內(nèi)毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method / rFC method.
純度(Purity)
>95% as determined by SDS-PAGE.
>90% as determined by SEC-MALS.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(chǔ)(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.



背景介紹
連接蛋白-4(Nectin-4,基因別名PVRL4)是一種66 kDa的I型跨膜糖蛋白,隸屬于免疫球蛋白超家族中的連接蛋白家族。該蛋白作為細(xì)胞黏附分子,在發(fā)育期及成體階段,對上皮細(xì)胞、內(nèi)皮細(xì)胞、免疫細(xì)胞和神經(jīng)細(xì)胞的極性建立、增殖分化及遷移等生物學(xué)過程具有關(guān)鍵調(diào)控作用。臨床研究表明,Nectin-4是重要的腫瘤相關(guān)抗原,在乳腺癌、卵巢癌和肺癌中的陽性表達(dá)率分別達(dá)50%、49%和86%,且主要存在于預(yù)后不良的腫瘤組織。值得注意的是,相應(yīng)正常組織中未檢測到該蛋白表達(dá)。
關(guān)鍵字: Nectin-4;Nectin-4蛋白;Nectin-4重組蛋白;ACRO;百普賽斯;
百普賽斯集團(tuán)ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺(tái)型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國、美國、瑞士等12個(gè)城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計(jì)服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。